Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555


Report Image
Global Regenerative Medicines Market (Technology, Application and Geography) - Size, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020
Published: Jun-2014    |    Formats: PDF & Excel   |   Author(s):Debbie Shields   |   Code: DI 14391
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology
  • Analyst's
    Review
  • Sample

Pages 114
Tables 33

Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. These medicines find applicability in wide range of degenerative disorders including dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers are engaged in developing technologies based on biologics, genes, somatic as well as stem cells.

The factors driving growth of this market include advancements in stem cell therapy, significance of nanotechnology and increasing incidences of degenerative diseases. Stem cells have unique ability of proliferation and differentiation. These cells can differentiate into any cell lineage. This distinctive characteristic of stem cells has made them of significant importance in this field. Additionally, the utilization of nano-materials in wound care, drug delivery and immunomodulation is opening growth avenues for the regenerative medicine market. However, the stringent regulations and the high cost of treatment act as hindrance for the progress of this market. The increasing focus on stem cells, their applications and the emerging economies would all contribute to the growth of this market. The developing nations are adopting technological advancements at a rapid pace, which would aid in the expansion of this market throughout the globe.

Reasons for Doing Study

Presently, majority of treatments available for degenerative or life-threatening diseases do not provide a cure or are palliative. Several others just postpone the progress of the disease. In contrary, regenerative medicines have the capability to replace or regenerate the tissues and organs suffering from injury or disease. These medicines find application in wide range of degenerative disorders and has proven to be efficient in many of the applications. Therefore, in-depth study of this market would provide an overall understanding of the market along with the growth opportunities in this field. The insights on applicable technologies and geographies would help the stakeholders in formulating strategic decisions.

Regenerative Medicine Market Analysis by Technology

On the basis of technology used, this market is segmented into small molecules & biologics, gene therapy and cell therapy. The small molecules and biologics segment have the largest contribution among all other technologies used for creating regenerative products. This is due to their efficiency in penetrating to internal membranes of the internal organs. However, gene therapies are expected to be the fastest emerging technology, growing at a CAGR of 28.6% during 2014-2020. The key reason for the growth of this technology can be attributed to the tremendous potential of gene therapy in minimizing immune rejections, which commonly occur after transplantations.

Regenerative Medicine Market Analysis by Applications

Based on its applications, this market can be classified into dermatology, cardiovascular, orthopaedic, central nervous system (CNS), dental and others. The cardiovascular applications have commercialized products as well as ongoing trials. Therefore, this is the largest revenue regenerating application market. However, due to immense focus on clinical studies in CNS disorders, this market is expected to gain momentum by 2020. The market for CNS is the fastest growing application segment at a CAGR of 30.8% during 2014-2020. This is due to recent approvals for a regenerative product intended to treat multiple sclerosis and increasing number of clinical trials for neurodegenerative disorders.

Regenerative Medicine Market Analysis by Geography

On the basis of geography, this market can be classified into North America, Europe, Asia-Pacific and LAMEA. Currently, North America dominates the global market due to heavy investment in development of regenerative products as well as more number of commercialized products. However, the growing focus on research and development in Japan and South Korea makes Asia-Pacific the fastest growing region at a CAGR of 30.9% during 2014-2020.

Competitive Analysis

The key companies included in the report are Shire Pharmaceuticals, Advanced Cell Technology, Genzyme, Athersys Inc., Kinetic Concepts, Inc., NuVasive, Stem Cells, Inc., Cytori Therapeutics, Inc., Cytomedix Inc. and Mesoblast Ltd. The primary strategy adopted by these companies is approval. These approvals are required prior to the initiation of clinical trials, during trials and for commercialization of these therapies. Secondly, some of the companies mentioned in the report acquired other company to enter into the field of regenerative medicines. These companies also entered in collaboration with research institutes or universities for conducting research and studies. The companies fostered these strategies to develop effective medications and therapies, thereby leading to product commercialization.

High Level Analysis

The report provides an analysis of the overall industrial scenario of regenerative medicines using Porter’s five forces model. The analysis advocates moderate bargaining power of suppliers and low bargaining power of buyers. The presence of limited number of suppliers increases their authority, whereas the prevailing stringent regulations lower their bargaining power. Therefore, the overall bargaining power of suppliers is moderate. On the other hand, the high cost of switching reduces the bargaining power of buyers. Furthermore, the inefficiency of the substitutes available for regenerative medicines lowers the threat from substitute in this market. The value chain analysis helps in assessment of primary and support activities for regenerative medicines.

Regenerative Medicines

KEY BENEFITS

  • The report provides an evaluation of drivers and restraints in this market, which would affect its growth. An assessment of opportunities is given to understand the growth avenues
  • The technology segment helps in understanding the present technologies used in this market
  • The application segment describes the availability of product based on type of diseases and discusses the ongoing studies for other disorders
  • The segmentation based on geography helps in analyzing advancements in regenerative medicine market throughout the globe
  • The projections in the report are made by analyzing the current market trends and future market potential for the period of 2013-2020
  • The key strategies adopted by the market players are discussed to provide an insight on the winning approaches followed by the companies
  • Porter’s five forces analysis is used to assess the present industrial scenario to help stakeholders in making decisive moves

KEY DELIVERABLES

The global regenerative medicine market is segmented based on technology, application and geography.

KEY MARKET SEGMENTS

MARKET BY TECHNOLOGY

  • Small molecules and Biologics
  • Gene therapy
  • Cell therapy

MARKET BY APPLICATION

  • Dermatology
  • Cardiovascular
  • CNS
  • Orthopedic
  • Dental
  • Others    
    • Autoimmune disorders
    • Muscle regeneration
    • Ocular diseases

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

CHAPTER 1. INTRODUCTION

1.1 Report description
1.2 Reasons for doing study
1.3 Key deliverables
1.4 Key benefits
1.5 Key audiences
1.6 Research methodology

1.6.1 Secondary research
1.6.2 Primary research
1.6.3 Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2025

2.2.1 Moderate Growth Scenario
2.2.2 Rapid Growth Scenario
2.2.3 Diminishing Growth Scenario

CHAPTER 3. GLOBAL REGENERATIVE MEDICINES MARKET OVERVIEW

3.1 Market definition and scope
3.2 Applications in organ regeneration
3.3 Nanotechnology

3.3.1 Nanoparticles
3.3.2 Nanoscaffolds

3.4 Materials for regenerative medicine

3.4.1 Synthetic materials
3.4.2 Biologically derived materials
3.4.3 Genetically modified materials

3.5 Key findings

3.5.1 Top factors impacting regenerative medicine market
3.5.2 Top winning strategies in the regenerative medicine market
3.5.3 Top investment pockets

3.6 Regulation and Reimbursement scenario
3.7 Porter’s five force analysis

3.7.1 Limited number of suppliers and stringent government regulations lead to moderate bargaining power of supplier
3.7.2 High cost of switching and differentiated products leads to lower bargaining power of buyers
3.7.3 Inefficiency of substitutes leads to lower threat from substitute products
3.7.4 High initial cost of investment leads to lower threats from new entrants
3.7.5 High exit barrier and rapid pace of growth leads to moderate intensity of rivalry

3.8 Value chain analysis

3.8.1 Primary activities
3.8.2 Supportive activities

3.9 Clinical trials
3.10 Drivers

3.10.1 Advancements in stem cell technology
3.10.2 Potential of nanotechnology
3.10.3 Increasing incidences of chronic Diseases and trauma injuries

3.11 Restraints

3.11.1 Stringent regulatory policies and ethical issues
3.11.2 Expensive treatment

3.12 Opportunities

3.12.1 Application of stem cells
3.12.2 Market in emerging nations

CHAPTER 4. GLOBAL REGENERATIVE MEDICINE MARKET BY TECHNOLOGIES

4.1 Small Molecules and Biologics

4.1.1 Key market trends
4.1.2 Competitive scenario
4.1.3 Key growth factors and opportunities
4.1.4 Market size & forecast

4.2 Gene Therapy

4.2.1 Key market trends
4.2.2 Competitive scenario
4.2.3 Key growth factors and opportunities
4.2.4 Market size & forecast

4.3 Cell Therapy

4.3.1 Key market trends
4.3.2 Competitive scenario
4.3.3 Key growth factors and opportunities
4.3.4 Market size & forecast

CHAPTER 5. GLOBAL REGENERATIVE MEDICINE MARKET BY APPLICATIONS

5.1 Dermatology
5.2 Cardiovascular Disorders
5.3 Central Nervous System (CNS)
5.4 Orthopedic
5.5 Dental
5.6 Others

5.6.1 Autoimmune Diseases
5.6.2 Muscle regeneration
5.6.3 Ocular Diseases
5.6.4 Internal organ regeneration

CHAPTER 6. GLOBAL REGENERATIVE MEDICINES MARKET BY GEOGRAPHY

6.1 North America

6.1.1 Key market trends
6.1.2 Competitive scenario
6.1.3 Market size & forecast
6.1.4 Key growth factors and opportunities

6.2 Europe

6.2.1 Key market trends
6.2.2 Competitive scenario
6.2.3 Key growth factors and opportunities
6.2.4 Market size & forecast

6.3 Asia pacific

6.3.1 Key market trends
6.3.2 Competitive scenario
6.3.3 Key growth factors and opportunities
6.3.4 Market size & forecast

6.4 LAMEA

6.4.1 Key market trends
6.4.2 Competitive scenario
6.4.3 Key growth factors and opportunities
6.4.4 Market size & forecast

CHAPTER 7. COMPANY PROFILES

7.1 Shire Pharmaceuticals

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Strategic moves and developments

7.1.4.1 Primary Strategies: Agreement
7.1.4.2 Secondary Strategies: Acquisition

7.1.5 SWOT Analysis of Shire Pharmaceuticals

7.2 Advanced Cell Technology, Inc

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Business performance
7.2.4 Strategic moves and developments

7.2.4.1 Strategies: APPROVAL

7.2.5 SWOT Analysis of Advanced Cell Technology

7.3 Genzyme

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Business performance
7.3.4 Strategic moves and developments

7.3.4.1 Strategies:Approval

7.3.5 SWOT Analysis of Genzyme

7.4 Athersys, Inc.

7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Business performance
7.4.4 Strategic moves and developments

7.4.4.1 Strategies

7.4.5 SWOT Analysis of Athersys, Inc.

7.5 Kinetic Concepts, Inc.

7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Business performance
7.5.4 Strategic moves and developments

7.5.4.1 Strategies

7.5.5 SWOT Analysis of Kinetic Concepts Inc.

7.6 NuVasive Inc.

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Business performance
7.6.4 Strategic moves and developments

7.6.4.1 Strategies

7.6.5 SWOT Analysis of NuVasive, Inc.

7.7 Stem cells, Inc.

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Strategic moves and developments

7.7.3.1 Primary Strategies: Approval
7.7.3.2 Secondary strategies

7.7.4 SWOT Analysis of Stem Cells, Inc.

7.8 Cytori Therapeutics, Inc.

7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Business performance
7.8.4 Strategic moves and developments

7.8.4.1 Strategies

7.8.5 SWOT Analysis of Cytori Therapeutics, Inc.

7.9 Cytomedix Inc.

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Strategic moves and developments

7.9.3.1 strategies

7.9.4 SWOT Analysis of Cytomedix Inc.

7.10 Mesoblast Ltd.

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Strategic moves and developments

7.10.3.1 strategies

7.10.4 SWOT Analysis of Mesoblast Ltd.

 

LIST OF TABLES

Table 1 Regenerative medicine market, by geography 2013-2020 ($million)

Table 2 Global regenerative medicine market by geography, moderate case 2020-2025 ($million)

Table 3 Global regenerative medicine market by geography, rapid case 2020-2025 ($million)

Table 4 Global regenerative medicine market by geography, diminishing case 2020-2025 ($million)

Table 5 Synthetic materials, applications and its trade names

Table 6 Global regenerative medicine market revenue, by technology 2013-2020 ($million)

Table 7 Global small molecules and biologics regenerative technology market, by geography 2013-2020 ($million)

Table 8 Global gene therapy regenerative technology market, by geography 2013-2020 ($million)

Table 9 Commercialized cell therapy products (2013)

Table 10 Global cell therapy regenerative technology market, by geography 2013-2020 ($million)

Table 12 Global regenerative medicine market revenue, by application 2013-2020 ($million)

Table 13 Global dermatology regenerative medicines application market, by geography 2013-2020 ($million)

Table 14 Global cardiovascular regenerative medicines application market, by geography 2013-2020

Table 15 Global CNS regenerative medicine application market, by geography 2013-2020 ($million)

Table 16 Global orthopedic  regenerative medicine application market, by geography 2013-2020 ($million)

Table 17 Global dental regenerative medicine application market, by geography 2013-2020 ($million)

Table 18 Global other regenerative medicine application market, by geography 2013-2020 ($million)

Table 19 Regenerative medicine market, by geography 2013-2020 ($million)

Table 20 North America regenerative medicine market, by application 2013-2020 ($million)

Table 21 Europe regenerative medicine market, by application 2013-2020 ($million)

Table 22 Asia Pacific regenerative medicine market, by application 2013-2020 ($million)

Table 23 LAMEA regenerative medicine market, by application 2013-2020 ($million)

Table 24 Shire Pharmaceuticals business snapshot

Table 25 Advanced Cell Technologies business snapshot

Table 26 Genzyme business snapshot

Table 27 Athersys, Inc. business snapshot

Table 28 Kinetic Concepts, INC. business snapshot

Table 29 Nuvasive, Inc. business snapshot

Table 30 Stem Cell, Inc. business snapshot

Table 31 Cytori Therapeutics, Inc. business snapshot

Table 32 Cytomedix, Inc. business snapshot

Table 33 Mesoblast Ltd. business snapshot

 

LIST OF FIGURES

Fig. 1 Top factors impacting regenerative medicine market (2013-2020)

Fig. 2 Top winning strategies of regenerative medicine market (2011-2014)

Fig. 3 Top wining strategies by subtype of developments

Fig. 4 Top investment pockets in regenerative medicine applications market

Fig. 5 Porter’s five force analysis

Fig. 6 Value chain analysis for regenerative medicine market

Fig. 7 The biologics market

Fig. 8 Commercialization of products as per applications (2013)

Fig. 9 SWOT analysis of shire pharmaceuticals

Fig. 10 SWOT analysis of advanced cell technology

Fig. 11 SWOT analysis of Genzyme

Fig. 12 SWOT analysis of Life Technologies

Fig. 13 SWOT analysis of Kinetic Concepts, Inc.

Fig. 14 SWOT analysis of Nuvasive, Inc.

Fig. 15 SWOT analysis of Stem Cells Inc.

Fig. 16 SWOT analysis of Cytori Therapeutics, Inc.

Fig. 17 SWOT analysis of Cytomedix, Inc.

Fig. 18 SWOT analysis of Mesoblast Ltd.

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

The bullish approach suggests a rapid change in market dynamics during 2020 to 2025. The advancements in stem cell research would accelerate its use for various regenerative disorders, thereby enhancing the pace of growth and providing a rapid growth scenario for this market. Additionally, the success of clinical trials in gene therapy would lead to product commercialization, which would further fuel the growth of this market. Presently, there exists a stringent government policy, which has restricted the pace of growth. However,a change in aptitude of government authorities is being observed, which would  benefit this market and the permissive policies would support accelerated growth in 2025. With innovation of novel therapies such as gene therapy and stem cell therapy, the cost of these medicines would also decline, hence aiding swift growth of this market.

SIMILAR MARKET STUDIES

Published Reports

DNA diagnostics is a cutting edge method which is set to revolutionize the field of medical diagnostics. This technique enables medical professionals to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same. It is also used for clinical diagnostic confirmation and in prenatal diagnostics.
27 2014 | Price: $4515(SU) | View Details >>

Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. Its a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.
27 May 2014 | Price: $4515(SU) | View Details >>

The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020. Bioinformatics is an interdisciplinary field that is used in the development and storage of data, thus helping in the analysis, organization and retrieval of the biological data. Bioinformatics has various applications and thus forms part of almost all the fields in biology. Bioinformatics form a part of agriculture, animal breeding, molecular medicine, preventive medicine, etc. The major factors driving the bioinformatics market is the need for integrated data, rising demand for drug development and discovery, the increasing focus in genomics & proteomics and the favorable government initiatives.
28 May 2014 | Price: $4515(SU) | View Details >>

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the fastest growing region. The key drivers for this market are the increase in the discovery of biomarkers and co-development of drug and corresponding diagnostic. However, cost associated with developing drugs could impede the growth of this market.
10 Jun 2014 | Price: $4515(SU) | View Details >>

Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. Other segments of this market include - Adult stem cell and embryonic stem cells. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies.
21 Jan 2014 | Price: $4515(SU) | View Details >>

Upcoming Reports

Veterinary diagnostics are noninvasive methods used to identify and examine the causes of diseases in animals. Various new technologies from human diagnostics segments are being adapted for the veterinary domain. This trend is expected to continue in the future, thereby contributing to the growth of this market.
Price: $4515 | Pre Book Price: $4515 | View Details >>

The label free detection method is used for detecting biomolecules and their interactions. This method has emerged as an attractive research and development tool in the pharmaceutical and biotech industry.
Price: $4515 | Pre Book Price: $4515 | View Details >>

DNA sequencing is a process used to determine the order of nucleotides within DNA molecules. Prenatal DNA sequencing is the method of sequencing the DNA isolated from pregnant women’s blood to reveal the full genetic code of a fetus. Prenatal DNA sequencing is used to sequence the whole genome of unborn baby that effectively detects the diseases
Price: $4515 | Pre Book Price: $4515 | View Details >>

Identification documents and PIN are traditional methods used to verify the identity of a human being. However, an increasing number of cases of security threats, illegal transactions at ATMs, unauthorised immigration and unauthorised infiltration across borders are factors which have resulted in the evolution of new generation biometrics methods. New generation biometrics refers to technologies that are used to verify the identity of individuals through biological characteristics such as facial expression, voice, palm, fingerprints, signature, iris, vein and DNA.
Price: $4515 | Pre Book Price: $4515 | View Details >>

STDs are sexually transmitted infections generally known as sexually transmitted diseases (STD) or venereal diseases. These are illness transmitted between humans as a result of sexual behavior. A variety of methods have been employed for the identification and assessment of these diseases based on their types. Some of the commonly known types of STDs are Gonorrhea, Syphilis and HIV AIDS. The objective of this report is to provide an in-depth understanding of the market scenario of diagnostic testing of STDs.
Price: $4515 | Pre Book Price: $4515 | View Details >>
First time Buyer ?
Check offer and
discount on this report


Get Discount

NEED MORE INFORMATION?
Call
+1 617 674 4143


Purchase Enquiry

PURCHASE OPTIONS

Single User
By obtaining a Single User License, you and your organization concur that only an individual uses this report either electronically or online. The right to use or stockpiling of the report should be confined only to one authorized computer. User will have authorization to print one duplicate of the report for individual use, yet may not be replicated for circulation. Additional copies for this report may also be order at discounted price for use by addition readers/users.
$4515

Multi User 
Multi-User license permits you to access the report from eight authorized computers. It does not permit you to display it on your company website and permits you to only print 5 copies of the report that shall not be reproduced for circulation.
$7515

Corporate  
With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report in is prohibited without the prior permission of Allied Market Research. The publisher will, in turn, regard the privacy of the purchaser and will keep it confidential. Upon buying single or multi-user license, buyer must provide the names and email ids of the authorized users of this report.
$10515


Not Interested in buying complete report?
To check the cost of chapters

WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader






Top